Krekeler, C.; Wethmar, K.; Mikesch, J.-H.; Kerkhoff, A.; Menck, K.; Lenz, G.; Schildhaus, H.-U.; Wessolly, M.; Hoffmann, M.W.; Pascher, A.;
et al. Complete Metabolic Response to Combined Immune Checkpoint Inhibition after Progression of Metastatic Colorectal Cancer on Pembrolizumab: A Case Report. Int. J. Mol. Sci. 2023, 24, 12056.
https://doi.org/10.3390/ijms241512056
AMA Style
Krekeler C, Wethmar K, Mikesch J-H, Kerkhoff A, Menck K, Lenz G, Schildhaus H-U, Wessolly M, Hoffmann MW, Pascher A,
et al. Complete Metabolic Response to Combined Immune Checkpoint Inhibition after Progression of Metastatic Colorectal Cancer on Pembrolizumab: A Case Report. International Journal of Molecular Sciences. 2023; 24(15):12056.
https://doi.org/10.3390/ijms241512056
Chicago/Turabian Style
Krekeler, Carolin, Klaus Wethmar, Jan-Henrik Mikesch, Andrea Kerkhoff, Kerstin Menck, Georg Lenz, Hans-Ulrich Schildhaus, Michael Wessolly, Matthias W. Hoffmann, Andreas Pascher,
and et al. 2023. "Complete Metabolic Response to Combined Immune Checkpoint Inhibition after Progression of Metastatic Colorectal Cancer on Pembrolizumab: A Case Report" International Journal of Molecular Sciences 24, no. 15: 12056.
https://doi.org/10.3390/ijms241512056
APA Style
Krekeler, C., Wethmar, K., Mikesch, J.-H., Kerkhoff, A., Menck, K., Lenz, G., Schildhaus, H.-U., Wessolly, M., Hoffmann, M. W., Pascher, A., Asmus, I., Wardelmann, E., & Bleckmann, A.
(2023). Complete Metabolic Response to Combined Immune Checkpoint Inhibition after Progression of Metastatic Colorectal Cancer on Pembrolizumab: A Case Report. International Journal of Molecular Sciences, 24(15), 12056.
https://doi.org/10.3390/ijms241512056